These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9718334)

  • 21. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
    Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
    Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N; Whaley J; Seizinger BR
    Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Type 2 neurofibromatosis: intergenerational differences in genetic and clinical expression].
    Drouet A; Le Moigne F; Salamé D; Quesnel L; Motolese C; des Portes V; Guilloton L; Pinson S
    Arch Pediatr; 2014 Nov; 21(11):1233-40. PubMed ID: 25439059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2.
    Kluwe L; Mautner VF
    Hum Genet; 1996 Feb; 97(2):224-7. PubMed ID: 8566958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?
    Evans DG; Ramsden RT; Gokhale C; Bowers N; Huson SM; Wallace A
    Clin Genet; 2007 Apr; 71(4):354-8. PubMed ID: 17470137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
    Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
    Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eleven novel mutations in the NF2 tumour suppressor gene.
    Bourn D; Evans G; Mason S; Tekes S; Trueman L; Strachan T
    Hum Genet; 1995 May; 95(5):572-4. PubMed ID: 7759081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.
    Sainz J; Huynh DP; Figueroa K; Ragge NK; Baser ME; Pulst SM
    Hum Mol Genet; 1994 Jun; 3(6):885-91. PubMed ID: 7951231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset.
    Smith MJ; Higgs JE; Bowers NL; Halliday D; Paterson J; Gillespie J; Huson SM; Freeman SR; Lloyd S; Rutherford SA; King AT; Wallace AJ; Ramsden RT; Evans DG
    J Med Genet; 2011 Apr; 48(4):261-5. PubMed ID: 21278391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors.
    Kluwe L; Friedrich RE; Hagel C; Lindenau M; Mautner VF
    J Invest Dermatol; 2000 May; 114(5):1017-21. PubMed ID: 10771486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurofibromatosis type 2 French cohort analysis using a comprehensive NF2 molecular diagnostic strategy.
    Pasmant E; Louvrier C; Luscan A; Cohen J; Laurendeau I; Vidaud M; Vidaud D; Goutagny S; Kalamarides M; Parfait B
    Neurochirurgie; 2018 Nov; 64(5):335-341. PubMed ID: 26073919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic Mosaicism of NF2 Gene Mutation with Constitutional NF1 Gene Mutation in Neurofibromatosis Type 2: a Case Report.
    Yoo SJ; Hwang YS
    Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.
    Parry DM; MacCollin MM; Kaiser-Kupfer MI; Pulaski K; Nicholson HS; Bolesta M; Eldridge R; Gusella JF
    Am J Hum Genet; 1996 Sep; 59(3):529-39. PubMed ID: 8751853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
    Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
    Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted deep sequencing of DNA from multiple tissue types improves the diagnostic rate and reveals a highly diverse phenotype of mosaic neurofibromatosis type 2.
    Teranishi Y; Miyawaki S; Hongo H; Dofuku S; Okano A; Takayanagi S; Ota T; Yoshimura J; Qu W; Mitsui J; Nakatomi H; Morishita S; Tsuji S; Saito N
    J Med Genet; 2021 Oct; 58(10):701-711. PubMed ID: 33067351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas.
    Wu CL; Thakker N; Neary W; Black G; Lye R; Ramsden RT; Read AP; Evans DG
    J Med Genet; 1998 Dec; 35(12):973-7. PubMed ID: 9863591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative genomic hybridization and mutation analyses of sporadic schwannomas.
    Ikeda T; Hashimoto S; Fukushige S; Ohmori H; Horii A
    J Neurooncol; 2005 May; 72(3):225-30. PubMed ID: 15937644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree.
    MacCollin M; Mohney T; Trofatter J; Wertelecki W; Ramesh V; Gusella J
    JAMA; 1993 Nov; 270(19):2316-20. PubMed ID: 8230593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation scanning of the NF2 gene: an improved service based on meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis.
    Wallace AJ; Watson CJ; Oward E; Evans DG; Elles RG
    Genet Test; 2004; 8(4):368-80. PubMed ID: 15684865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.